Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg.

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Abstract Text:

The efficacy of allogeneic cultured dermal substitute (CDS) on wound healing was evaluated in six patients with intractable skin ulcers on the lower extremities. Allogeneic CDS was repeatedly applied to wounds at intervals of 4-7 days to prepare a wound bed acceptable for skin grafting or to induce resurfacing through the granulation tissue formation associated with epithelialization. In one patient with a leg ulcer, the wound size decreased to 32% of the original size within 10 weeks and skin grafting was conducted. In the other five patients with leg, ankle, or foot ulcers, the wound size decreased to 9%-25% of the original size within 6 weeks.

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of artificial organs : the official journa

VOLUME: 11

Page Numbers: 100-3

Journal Abbreviation:

ISSN: 1434-7229

DAY: 6

MONTH: 07

YEAR: 2008

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9815648

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg.

AFFILIATION: Department of Plastic and Aesthetic Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, 228-8555, Japan, ymprs@med.kitasato-u.ac.jp.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Artif Organs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg Related Publications

• Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
• Beyerane Derivatives and a Sesquiterpene Dimer from Japanese Cypress (Chamaecyparis obtusa).
• Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg.
• Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation.
• Development of new wound dressing composed of spongy collagen sheet containing dibutyryl cyclic AMP.
• Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute.
• Novel Lanostane and Rearranged Lanostane-Type Triterpenoids from Abies sachalinensis-II-.
• Rapid identification of triterpenoid saponins in the roots of Codonopsis lanceolata by liquid chromatography-mass spectrometry.
• Rearranged Lanostane Triterpenoids from Abies sachalinensis (III).
• STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo.
• Triterpene Glycosides from the Roots of Codonopsis lanceolata.